Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


19.05.2025

1 Adv Sci (Weinh)
1 AIDS Behav
2 Am J Obstet Gynecol
1 Anal Cell Pathol (Amst)
1 Ann Ital Chir
1 Anticancer Drugs
1 BMC Cancer
1 BMC Infect Dis
2 BMC Public Health
1 BMC Womens Health
1 Cancer Manag Res
1 Cancers (Basel)
1 Clin Obstet Gynecol
1 Comb Chem High Throughput Screen
1 Cost Eff Resour Alloc
1 Cureus
1 Curr Med Imaging
1 Curr Treat Options Oncol
2 Diagnostics (Basel)
1 Dis Markers
2 Discov Oncol
1 Environ Toxicol
6 Eur J Surg Oncol
2 Front Immunol
2 Front Med (Lausanne)
2 Front Oncol
1 Gulf J Oncolog
1 Health SA
1 Healthcare (Basel)
1 IEEE J Biomed Health Inform
1 Immunopharmacol Immunotoxicol
1 Implement Sci
3 Int J Cancer
1 Int J Gen Med
1 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
5 Int J Mol Sci
2 Int J Radiat Oncol Biol Phys
1 Int J Womens Health
1 J Affect Disord
1 J Clin Microbiol
2 J Community Health
1 J Gynecol Oncol
1 J Health Care Poor Underserved
1 J Obstet Gynaecol Res
1 JAMA Netw Open
2 JCO Glob Oncol
1 JNCI Cancer Spectr
1 JSLS
1 Lakartidningen
1 Microsc Res Tech
1 Neoplasma
1 Niger Postgrad Med J
1 Obstet Gynecol
1 Oncogene
1 Oncologist
1 Pathol Oncol Res
1 PLOS Glob Public Health
2 Radiat Oncol
1 Sci Rep
1 Sensors (Basel)
1 Toxicol Rep
2 Vaccine
1 World J Surg Oncol
1 Zhongguo Zhong Yao Za Zhi
1 Zhonghua Yu Fang Yi Xue Za Zhi
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Sci (Weinh)

  1. YAO S, Chen S, Wang A, Liang Z, et al
    BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING.
    Adv Sci (Weinh). 2025 May 14:e70005. doi: 10.1002/advs.202414637.
    PubMed         Abstract available


    AIDS Behav

  2. KABARAMBI A, Kizito S, Hunleth J, Silver MI, et al
    HPV Vaccine Uptake and its Predictors among Adolescent Girls and Young Women Living with HIV-in Central Uganda.
    AIDS Behav. 2025;29:1859-1865.
    PubMed         Abstract available


    Am J Obstet Gynecol

  3. KANBERGS A, Clapp M, Wu CF, Melamed A, et al
    Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity.
    Am J Obstet Gynecol. 2024 Oct 22:S0002-9378(24)01083.
    PubMed         Abstract available

  4. LYCKE KD, Steben M, Garland SM, Woo YL, et al
    An updated understanding of the natural history of cervical human papillomavirus infection-clinical implications.
    Am J Obstet Gynecol. 2025;232:453-460.
    PubMed         Abstract available


    Anal Cell Pathol (Amst)

  5. SSEDYABANE F, Niyonzima N, Ngonzi J, Najjuma JN, et al
    Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control Study.
    Anal Cell Pathol (Amst). 2025;2025:1931921.
    PubMed         Abstract available


    Ann Ital Chir

  6. HAN H, Zhou H, He J, Zhang X, et al
    An Explainable Deep Learning Framework for Predicting Postoperative Radiotherapy-Induced Vaginal Stenosis in Surgically Treated Cervical Cancer Patients.
    Ann Ital Chir. 2025;96:602-616.
    PubMed         Abstract available


    Anticancer Drugs

  7. ZHANG R, Hou F, Gan J, Zhang L, et al
    Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation.
    Anticancer Drugs. 2025;36:468-477.
    PubMed         Abstract available


    BMC Cancer

  8. LI ZR, Wang YF, Zuo CR, Men JS, et al
    Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review.
    BMC Cancer. 2025;25:863.
    PubMed         Abstract available


    BMC Infect Dis

  9. WANG H, Jin P
    Risk stratification and conservative management of women aged 25-40 years with cervical intraepithelial neoplasia grade 2(CIN2).
    BMC Infect Dis. 2025;25:696.
    PubMed         Abstract available


    BMC Public Health

  10. BULA AK, Mhango P, Tsidya M, Chimwaza W, et al
    Client perspectives and satisfaction with integrating facility and community-based HPV self-sampling for cervical cancer screening with family planning: a mixed method study.
    BMC Public Health. 2025;25:1718.
    PubMed         Abstract available

  11. TANG WZ, Cai QY, Huang KJ, Xu WZ, et al
    The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021.
    BMC Public Health. 2025;25:1774.
    PubMed         Abstract available


    BMC Womens Health

  12. SUN M, Xu B, Yu J, Wu Y, et al
    Outcomes following conization and factors on HPV regression among young females in Wuxi.
    BMC Womens Health. 2025;25:223.
    PubMed         Abstract available


    Cancer Manag Res

  13. KUANG H, Yang D, Lin R, Tang Y, et al
    A Nomogram Based on Fibrinogen-to-Neutrophil Ratio as a Novel Predictor of Lymph Node Metastasis in Patients with Cervical Cancer and Type 2 Diabetes Mellitus.
    Cancer Manag Res. 2025;17:933-954.
    PubMed         Abstract available


    Cancers (Basel)

  14. BARTOSZEWSKA E, Czapla M, Rakoczy K, Filipski M, et al
    The Role of Ion Channels in Cervical Cancer Progression: From Molecular Biomarkers to Diagnostic and Therapeutic Innovations.
    Cancers (Basel). 2025;17:1538.
    PubMed         Abstract available


    Clin Obstet Gynecol

  15. STOKES MJ, Ramirez PR, Spencer NM, Nelson EL, et al
    Human Papillomavirus Infections and Sequela in Women.
    Clin Obstet Gynecol. 2025;68:188-193.
    PubMed         Abstract available


    Comb Chem High Throughput Screen

  16. LYU G, Li J, Li D
    KLHL17 as a Prognostic Indicator and Therapeutic Target in Cervical Cancer: A Comprehensive Analysis.
    Comb Chem High Throughput Screen. 2025.
    PubMed         Abstract available


    Cost Eff Resour Alloc

  17. ZHOU D, Zhang D, Wang Y, Zhou K, et al
    Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysis.
    Cost Eff Resour Alloc. 2025;23:20.
    PubMed         Abstract available


    Cureus

  18. OKUNOWO AA, Anumni CC, Habeebu MY, Olayioye OM, et al
    Reproductive and Sexual Predictors of Late-Stage Cervical Cancer Presentation in Lagos, Nigeria.
    Cureus. 2025;17:e81934.
    PubMed         Abstract available


    Curr Med Imaging

  19. KARTHIKEYAN N, Chandrasekaran G, Sudha S
    CERVIXNET: An Efficient Approach for the Detection and Classifications of the Cervigram Images Using Modified Deep Learning Architecture.
    Curr Med Imaging. 2025;21:e15734056343690.
    PubMed         Abstract available


    Curr Treat Options Oncol

  20. GARDNER UG, Viswanathan AN
    Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy.
    Curr Treat Options Oncol. 2025 May 15. doi: 10.1007/s11864-025-01325.
    PubMed         Abstract available


    Diagnostics (Basel)

  21. MUALLEM MZ, Sayasneh A
    Debunking Myths and Misinformation in Cervical Cancer: A Narrative Review on Navigating Complex Treatment Choices in Locally Advanced Cases and Exploring Beyond Standard Protocols.
    Diagnostics (Basel). 2025;15:1174.
    PubMed         Abstract available

  22. GOMES M, Provaggi E, Pembe AB, Olaitan A, et al
    Advancing Cervical Cancer Prevention Equity: Innovations in Self-Sampling and Digital Health Technologies Across Healthcare Settings.
    Diagnostics (Basel). 2025;15:1176.
    PubMed         Abstract available


    Dis Markers

  23. MARKERS D
    RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
    Dis Markers. 2025;2025:9817180.
    PubMed         Abstract available


    Discov Oncol

  24. YU J, Zhang Y
    Mendelian randomization analysis of immune cell traits and their association with cervical cancer risk.
    Discov Oncol. 2025;16:709.
    PubMed         Abstract available

  25. DENG J, Li Y, Zhang L, Liao W, et al
    Piezo1 regulates actin cytoskeleton remodeling to drive EMT in cervical cancer through the RhoA/ROCK1/PIP2 signaling pathway.
    Discov Oncol. 2025;16:787.
    PubMed         Abstract available


    Environ Toxicol

  26. ZHANG X, Yang J, Feng Q, Gu L, et al
    The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
    Environ Toxicol. 2025;40:902-911.
    PubMed         Abstract available


    Eur J Surg Oncol

  27. CELEBIC A, Miladinovic M, Jakimovska Stefanovska M, Calleja-Agius J, et al
    Sentinel lymph node biopsy in gynecological malignancies: A modern approach to surgical staging - A narrative review.
    Eur J Surg Oncol. 2025;51:109757.
    PubMed         Abstract available

  28. CELEBIC A, Harasani K, Miladinovic M, Mandic A, et al
    Neuroendocrine tumors of the gynecological tract: A narrative literature review.
    Eur J Surg Oncol. 2025;51:109735.
    PubMed         Abstract available

  29. DI FIORE R, Drago-Ferrante R, Suleiman S, Calleja N, et al
    The role of microRNA-9 in ovarian and cervical cancers: An updated overview.
    Eur J Surg Oncol. 2025;51:108546.
    PubMed         Abstract available

  30. MAXOVA K, Rehackova M, Jirkovska M, Robova H, et al
    Postoperative quality of life in patients with early-stage cervical cancer: A prospective 10-year follow-up study.
    Eur J Surg Oncol. 2025;51:110119.
    PubMed         Abstract available

  31. CARUSO G, Gaiano M, De Vitis LA, Stefani E, et al
    Predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery.
    Eur J Surg Oncol. 2025;51:110121.
    PubMed         Abstract available

  32. CELEBIC A, Jakimovska Stefanovska M, Miladinovic M, Calleja-Agius J, et al
    Evaluating the role of robotic surgery in gynecological cancer treatment.
    Eur J Surg Oncol. 2025;51:109630.
    PubMed         Abstract available


    Front Immunol

  33. LANG J, Liu Q, Ji R, Qiu M, et al
    Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case repor
    Front Immunol. 2025;16:1573202.
    PubMed         Abstract available

  34. WANG W, Huang C, Bi S, Liang H, et al
    A predictive model for the transformation from cervical inflammation to cancer based on tumor immune-related factors.
    Front Immunol. 2025;16:1532048.
    PubMed         Abstract available


    Front Med (Lausanne)

  35. ZHANG Y, Rong L, Jiang H, Mu X, et al
    Construction and validation of nomograms for predicting overall survival and cause-specific survival in cervical cancer patients undergoing radical radiotherapy based on the SEER database.
    Front Med (Lausanne). 2025;12:1587465.
    PubMed         Abstract available

  36. CHENG X, Wang P, Cheng L, Zhao F, et al
    Trends in cervical cancer incidence and mortality in the United States, 1975-2018: a population-based study.
    Front Med (Lausanne). 2025;12:1579446.
    PubMed         Abstract available


    Front Oncol

  37. FALUDI VARGANE E, Ghanem AS, Nguyen CM, Pataki J, et al
    Influencing factors on attendance in cervical cancer screening among women with diabetes in Hungary: a cross-sectional study using European Health Interview Surveys 2009-2019.
    Front Oncol. 2025;15:1501654.
    PubMed         Abstract available

  38. MUHETAER G, He X, Yang C, Guo F, et al
    Single-cell combined transcriptome probes prognostic mechanisms of sialylation-related genes in cervical cancer.
    Front Oncol. 2025;15:1534247.
    PubMed         Abstract available


    Gulf J Oncolog

  39. NEWADKAR ND, Khandeparkar SGS, Gogate BP, Gotekar A, et al
    Immunohistochemical Study of Cyclin D1 and HER2/neu in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.
    Gulf J Oncolog. 2024;1:14-23.
    PubMed         Abstract available


    Health SA

  40. MOSALO A, Maree JE
    Supporting women undergoing radiotherapy for cervical cancer: A pilot intervention.
    Health SA. 2025;30:2815.
    PubMed         Abstract available


    Healthcare (Basel)

  41. ZHOU SH, He YQ, Diao H, Yang DW, et al
    Mediation of Ethnic Disparity in the 5-Year Mortality of Cervical Cancer Patients in the US, 2001-2019.
    Healthcare (Basel). 2025;13:964.
    PubMed         Abstract available


    IEEE J Biomed Health Inform

  42. CHEN Y, Jiang H, Pang W, Diao Z, et al
    Multi-Task Collaborative Assisted Training Method for Grouping Fuzzy Categories Classification of Cervical Cancer Cells.
    IEEE J Biomed Health Inform. 2025;PP.
    PubMed         Abstract available


    Immunopharmacol Immunotoxicol

  43. HENRY M, Ngwegya T, Lekena N, Barth S, et al
    In vitro anti-tumour activities of a novel recombinant immunotoxin targeting differentially overexpressed Leucine-rich repeat-containing G-protein-coupled receptor 5 in cervical cancer.
    Immunopharmacol Immunotoxicol. 2025.
    PubMed         Abstract available


    Implement Sci

  44. CHAO CR, Cannizzaro N, Hahn EE, Shen E, et al
    A pragmatic randomized trial to compare strategies for implementing primary HPV testing for routine cervical cancer screening in a large healthcare system.
    Implement Sci. 2025;20:21.
    PubMed         Abstract available


    Int J Cancer

  45. CHANDRAN A, Mackie A, Sasieni P, Arbyn M, et al
    Technical, legal and ethical framework of cancer audit in cervical screening - Summary of best practices for organised programmes delineated through an expert group consultation.
    Int J Cancer. 2025;157:32-40.
    PubMed         Abstract available

  46. BOWDEN SJ, Bodinier B, Paraskevaidi M, Kalliala I, et al
    DNA methylation signatures of cervical pre-invasive and invasive disease: An epigenome-wide association study.
    Int J Cancer. 2025;157:305-316.
    PubMed         Abstract available

  47. BJORGE T, Stoer NC, Hverven SK, Nygard M, et al
    Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study.
    Int J Cancer. 2025;157:251-259.
    PubMed         Abstract available


    Int J Gen Med

  48. GAO YY, Li XX, Zuo H, Zhang P, et al
    Analysis of the Relationship Between Cervical Cancer Progression and the Microbiome.
    Int J Gen Med. 2025;18:2449-2460.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  49. LI DM, Liu QY, Xue SL, Zeng X, et al
    Accuracy analysis of cervical cancer screening using urine and vaginal self-sampling versus clinician-collected samples: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70207.
    PubMed         Abstract available


    Int J Gynecol Cancer

  50. FRENEL JS, Roynard T, Loaec C, Ray-Coquard I, et al
    Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management.
    Int J Gynecol Cancer. 2025;35:101908.
    PubMed        

  51. LOU J, Li Y, Li R, Guo Y, et al
    Association between magnetic resonance imaging-measured bone marrow cellularity and clinical outcomes among patients with cervical cancer treated with programmed cell death protein-1 inhibitors.
    Int J Gynecol Cancer. 2025;35:101808.
    PubMed         Abstract available

  52. DOSTALEK L, Brynda D, Marek R, Hederlingova J, et al
    Regression of high-grade squamous intraepithelial cervical lesions and associated risk factors (RECER).
    Int J Gynecol Cancer. 2025;35:101768.
    PubMed         Abstract available


    Int J Mol Sci

  53. HONG MK, Wang JH, Li MH, Su CC, et al
    Topological Distribution of the Sex Hormone Receptor Expressions Highlights the Importance of Stromal ERalpha and Epithelial PR in Malignant Transformation of the Uterine Cervix.
    Int J Mol Sci. 2025;26:4418.
    PubMed         Abstract available

  54. SCHELLEKENS HCJ, Schmidt LMS, Morre SA, van Esch EMG, et al
    Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review.
    Int J Mol Sci. 2025;26:3954.
    PubMed         Abstract available

  55. ZHOU E, Bhoora S, Pillay TS, Punchoo R, et al
    Induction of Cell Death and Regulation of Autocrine Vitamin D Metabolism in Cervical Cancer by Physiological and GI20 Doses of 25-Hydroxycholecalciferol.
    Int J Mol Sci. 2025;26:4008.
    PubMed         Abstract available

  56. PASZTOR R, Viskolcz B, Olah C, Varadi C, et al
    Comparative Analysis of Serum N-Glycosylation in Endometriosis and Gynecologic Cancers.
    Int J Mol Sci. 2025;26:4105.
    PubMed         Abstract available

  57. WEN H, Zhang Y, Liu Y, Long H, et al
    The Significance of Circulating Microbial Signatures in the Prognosis and Immune Microenvironment of Patients with Cervical Cancer.
    Int J Mol Sci. 2025;26:4293.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  58. KNOTH J, Nout RA, Potter R, Mahantshetty DU, et al
    Distant metastasis after chemoradiation and IGABT in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
    PubMed         Abstract available

  59. SAPIENZA LG, Chapman CH, Jhavar S, Calsavara VF, et al
    Understanding hydronephrosis occurrence by an individual-kidney level analysis of all events post-chemoradiotherapy for locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 8:S0360-3016(25)00430.
    PubMed         Abstract available


    Int J Womens Health

  60. GUO P, Wu L, Wang H, Wang L, et al
    The Relationship between Systemic Expression Levels of Immune Cells and Tumor Markers and High-Risk HPV Infection in Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Chronic Cervicitis, and its Clinical Significance.
    Int J Womens Health. 2025;17:1263-1270.
    PubMed         Abstract available


    J Affect Disord

  61. WANG F, Liu Y, Jia J, Bai X, et al
    Causality between 22 personal traits and cervical cancer: a two-sample Mendelian randomization study.
    J Affect Disord. 2025 May 12:S0165-0327(25)00780.
    PubMed         Abstract available


    J Clin Microbiol

  62. MILANOVA V, Gomes M, Mihaylova K, Twelves JL, et al
    Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study.
    J Clin Microbiol. 2025 Apr 11:e0185224. doi: 10.1128/jcm.01852.
    PubMed         Abstract available


    J Community Health

  63. ADEGBOYEGA A, Leshi O, Obielodan O, Wiggins AT, et al
    Association of Cancer Risk Perception and Patient-provider Communication with Pap Test Among African American and Sub-Saharan African-born Women.
    J Community Health. 2025;50:434-441.
    PubMed         Abstract available

  64. SOLAK B, Arslan M
    Evaluation of HPV and Related Cancer Awareness and Vaccination Attitudes Among Patients with Anogenital Warts: a Survey-Based Study.
    J Community Health. 2025;50:560-567.
    PubMed         Abstract available


    J Gynecol Oncol

  65. BARTL T, Dorittke T, Ciocsirescu C, Knoth J, et al
    Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy.
    J Gynecol Oncol. 2025 Apr 24. doi: 10.3802/jgo.2025.
    PubMed         Abstract available


    J Health Care Poor Underserved

  66. AUGUST C, Barroeta JE, Conant JL, Paintal RD, et al
    Using See, Test & Treat(R) to Increase Uptake of Breast and Cervical Cancer Screenings: Report from the Field.
    J Health Care Poor Underserved. 2025;36:757-764.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  67. GAO Z, Yin Z, Sun L, Zhao H, et al
    Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage IIIC1 cervical adenocarcinoma: A retrospective multicenter cohort study.
    J Obstet Gynaecol Res. 2025;51:e16307.
    PubMed         Abstract available


    JAMA Netw Open

  68. TARNEY CM, Tian C, Randall LM, Hussain SA, et al
    Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical Hysterectomy.
    JAMA Netw Open. 2025;8:e2510717.
    PubMed         Abstract available


    JCO Glob Oncol

  69. GROVER S, Moorkanat GG, Ketlametswe R, Monare B, et al
    Impact of the COVID-19 Pandemic on Cervical Cancer Treatment Delays in Botswana.
    JCO Glob Oncol. 2025;11:e2400300.
    PubMed         Abstract available

  70. ISEME-ONDIEK R, Abuodha J, Ngugi A, Abayo I, et al
    Insights Into Cancer Awareness and Health Practices in Rural Kenya: A Cross-Sectional Study of Esophageal, Breast, Prostate, Cervical, and Colorectal Cancers.
    JCO Glob Oncol. 2025;11:e2400421.
    PubMed         Abstract available


    JNCI Cancer Spectr

  71. GROVER S, Bhatia R, Zhang S, Khan S, et al
    Cervical cancer treatment outcomes and survival in Botswana by HIV status: Ipabalele study results.
    JNCI Cancer Spectr. 2025 May 8:pkaf045. doi: 10.1093.
    PubMed         Abstract available


    JSLS

  72. PUNTAMBEKAR S, Parulekar M, Venkateswaran S, Naidu S, et al
    Comparative Outcomes of Laparoscopic Radical Hysterectomy and Nerve-Sparing Technique in Cervical Cancer Patients.
    JSLS. 2025;29:e2024.
    PubMed         Abstract available


    Lakartidningen

  73. DILLNER J, Gray P
    [HPV screening coverage and cancer].
    Lakartidningen. 2025;122:25007.
    PubMed         Abstract available


    Microsc Res Tech

  74. IDLAHCEN F, Mboukou PFC, Idri A, El Attar H, et al
    PathoCoder: Rethinking the Flaws of Patch-Based Learning for Multi-Class Classification in Computational Pathology.
    Microsc Res Tech. 2025;88:1712-1726.
    PubMed         Abstract available


    Neoplasma

  75. KE X, Li L, Yan Q, Wang X, et al
    EGFR/STAT3 signaling mediates the upregulation of CD47 in HPV-positive cervical cancer by activating p65 and exosome transporter RAB31.
    Neoplasma. 2025;72.
    PubMed         Abstract available


    Niger Postgrad Med J

  76. AKAN A, Omo-Aghoja L, Adeyinka A
    The Diagnostic Performance of Pap Smear during Both Phases of the Menstrual Cycle: A Community-based Study in Southern Nigeria.
    Niger Postgrad Med J. 2025;32:120-126.
    PubMed         Abstract available


    Obstet Gynecol

  77. LI S, Oatman E, Tanyi J, Kim SH, et al
    Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With Cervical Cancer.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005932.
    PubMed         Abstract available


    Oncogene

  78. ZHANG C, Jiang H, Yuan L, Liao Y, et al
    Correction: CircVPRBP inhibits nodal metastasis of cervical cancer by impeding RACK1 O-GlcNAcylation and stability.
    Oncogene. 2025 May 15. doi: 10.1038/s41388-025-03440.
    PubMed        


    Oncologist

  79. LYAMUYA T, Mchome B, Stroetmann CY, Machange R, et al
    Barriers to adherence to cervical cancer screening care in Northern Tanzania.
    Oncologist. 2025;30:oyaf111.
    PubMed         Abstract available


    Pathol Oncol Res

  80. VEGVARY Z, Koszo R, Egyud Z, Varga L, et al
    MRI-based image-guided adaptive brachytherapy for locally advanced cervical cancer in clinical routine: a single-institution experience.
    Pathol Oncol Res. 2025;31:1612077.
    PubMed         Abstract available


    PLOS Glob Public Health

  81. ISLAM MF, Nessa A, Zaki QA, Akbar Ashrafi SA, et al
    Evaluation of the National cervical cancer surveillance program in Bangladesh: Performance, strengths, and opportunities for improvement.
    PLOS Glob Public Health. 2025;5:e0004595.
    PubMed         Abstract available


    Radiat Oncol

  82. WEI S, Hu A, Liang Y, Yang J, et al
    Feasibility study of automatic radiotherapy treatment planning for cervical cancer using a large language model.
    Radiat Oncol. 2025;20:77.
    PubMed         Abstract available

  83. JIA SZ, Yang D, Yang XJ, Wang R, et al
    Risk stratification of node-positive early-stage cervical cancer treated with radical hysterectomy followed by chemoradiotherapy: a retrospective single-center study.
    Radiat Oncol. 2025;20:73.
    PubMed         Abstract available


    Sci Rep

  84. HARIPRASAD R, Srinivasan M, Ravi P, Tamang H, et al
    A qualitative study on ASHA workers' perspective on HPV self-sampling in Sikkim India.
    Sci Rep. 2025;15:15985.
    PubMed         Abstract available


    Sensors (Basel)

  85. RAZA MA, Siddiqui HUR, Saleem AA, Zafar K, et al
    Advanced Feature Extraction for Cervical Cancer Image Classification: Integrating Neural Feature Extraction and AutoInt Models.
    Sensors (Basel). 2025;25:2826.
    PubMed         Abstract available


    Toxicol Rep

  86. PARVEEN S, Ahtsham A, Kumar S, Gupta P, et al
    Piperlongumine mediated apoptosis in cervical cancer cells beyond docking predictions.
    Toxicol Rep. 2025;14:102031.
    PubMed         Abstract available


    Vaccine

  87. YUILL S, Hall MT, Caruana M, Lui G, et al
    Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010-2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening.
    Vaccine. 2025;54:126986.
    PubMed         Abstract available

  88. XIE F, Du K, Li J, Zhong S, et al
    Head-to-head immunogenicity comparison of one-dose Cecolin and Gardasil in Chinese girls aged 9-14 years: A randomized and open-label clinical trial.
    Vaccine. 2025;55:127015.
    PubMed         Abstract available


    World J Surg Oncol

  89. ZHU T, Chen Z, Zhang B, Wu X, et al
    Prognostic value of platelet to lymphocyte ratio in patients with cervical cancer: an updated systematic review and meta-analysis.
    World J Surg Oncol. 2025;23:187.
    PubMed         Abstract available


    Zhongguo Zhong Yao Za Zhi

  90. HONG DD, Shang TT, Guo HY, Zuo WT, et al
    [Role of Toll-like receptors in persistent infection of cervical high-risk human papillomavirus based on "latent pathogen theory"].
    Zhongguo Zhong Yao Za Zhi. 2025;50:1974-1979.
    PubMed         Abstract available


    Zhonghua Yu Fang Yi Xue Za Zhi

  91. YE ZC, Lu Q, Xue P, Jiang Y, et al
    [A Meta-analysis of the application of artificial intelligence in cervical cytopathology diagnosis].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:572-580.
    PubMed         Abstract available


    Zhonghua Zhong Liu Za Zhi

  92. WANG H, Liu Y, Xu HF, Chen PP, et al
    [Evaluation of high-risk HPV genotyping detection in cervical cancer screening based on a prospective cohort study].
    Zhonghua Zhong Liu Za Zhi. 2025;47:435-442.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.